Research Priorities
Study finds no increase in traffic injuries after cannabis legalization
By Stephanie Chow | November 10, 2021
Researchers looked at traffic-injury emergency department visits for all drivers in Alberta and Ontario.
New portable MRI has the potential to transform access to health care
By dcc2012 | November 9, 2021
UBC researchers will investigate how the system can improve patient access to MRI to enable faster diagnosis and better disease management.
Life expectancy varies by as much as 9.5 years across Metro Vancouver
By dcc2012 | November 4, 2021
First-in-Canada study reveals inequality between neighbourhoods has grown considerably since 2001.
Halting COVID-19 in its tracks
By Kerry Blackadar | November 4, 2021
UBC researchers are investigating a novel aerosol treatment to stop the virus from replicating.
Spending time in nature promotes early childhood development
By Stephanie Chow | October 21, 2021
New UBC research suggests living in areas with high exposure to greenspace can help set children up for success.
New text-message program helps ease transition to parenthood
By aemccull | October 8, 2021
UBC’s Dr. Patricia Janssen introduces SmartParent, Canada’s first parenting education program delivered by text message.
Cancer chemotherapy drug reverses Alzheimer’s symptoms in mice
By dcc2012 | October 5, 2021
UBC researchers have found Axitinib can restore memory and cognitive function in mice.
Shannon Kolind and Tamara Vanderwal awarded $100K Brain Canada grants
By dcc2012 | September 9, 2021
Drs. Kolind and Vanderwal are among 20 early-career researchers recently awarded these grants.
Chemotherapy drug puts young children with cancer at high risk of hearing loss
By dcc2012 | September 7, 2021
75 per cent of patients five years old and younger had experienced cisplatin-related hearing loss three years after starting therapy.
New study examines ‘Achilles’ heel’ of cancer tumours, paving the way for new treatment strategies
By dcc2012 | August 27, 2021
UBC and BC Cancer researchers have uncovered a weakness in a key enzyme that solid tumour cancer cells rely on to adapt and survive.